|
Market Closed -
Other stock markets
|
Pre-market 19:55:01 | |||
| 44.20 USD | -0.58% |
|
44.50 | +0.68% |
| 06-25 | Major deals involving US drugmakers and biotechs over the past decade | RE |
| 06-25 | Stifel Adjusts Price Target on Boston Scientific to $65 From $75, Maintains Buy Rating | MT |
| Market Cap | 65.7B 57.8B 53.24B 49.81B 93.26B 6,201B 95.11B 639B 247B 3,057B 247B 241B 10,629B | P/E 2026 * |
16.2x | P/E 2027 * | 15.4x |
|---|---|---|---|---|---|
| Enterprise Value | 72.86B 64.1B 59.05B 55.24B 103B 6,876B 105B 709B 274B 3,390B 274B 268B 11,787B | EV / Sales 2026 * |
3.37x | EV / Sales 2027 * | 2.99x |
| Free-Float |
84.76% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Boston Scientific Corporation
| 1 day | +0.79% | ||
| 1 week | -1.67% | ||
| Current month | -8.51% | ||
| 1 month | -23.50% | ||
| 3 months | -35.14% | ||
| 6 months | -54.02% | ||
| Current year | -53.64% |
| 1 week | 43.89 |  | 45.83 |
| 1 month | 43.89 | | 58.14 |
| Current year | 43.89 | | 100.9 |
| 1 year | 43.89 | | 109.5 |
| 3 years | 43.89 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 2011-10-31 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 2025-06-29 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 2009-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 2016-05-02 |
Edward Ludwig
BRD | Director/Board Member | 74 | 2014-02-28 |
Ellen Zane
BRD | Director/Board Member | 74 | 2016-04-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-27 | Don | Chief Executive Officer | -386,755 | 0.0261% | ||
| 05-19 | Buy | Director | 1,770 | 0.0001% | ||
| 05-19 | Buy | Director | 2,250 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.58% | -1.67% | -57.55% | -18.10% | 66.08B | |
| +2.75% | +9.54% | +25.07% | -3.52% | 183B | |
| -0.53% | -0.62% | -23.59% | +22.13% | 142B | |
| +2.30% | +8.69% | -2.16% | -18.88% | 134B | |
| +0.07% | +3.51% | +18.29% | -0.69% | 51.63B | |
| +0.50% | -0.72% | -26.65% | -32.86% | 43.38B | |
| +2.95% | +8.99% | +15.19% | +13.47% | 37.18B | |
| +2.09% | +5.57% | +8.68% | +45.05% | 36.25B | |
| +0.09% | +6.20% | -9.78% | -18.64% | 29.51B | |
| +1.07% | +6.61% | -22.39% | -7.74% | 28.38B | |
| Average | +1.05% | +0.31% | -7.49% | -1.98% | 75.13B | |
| Weighted average by Cap. | +1.19% | -0.37% | -4.15% | -1.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.59B 19B 17.5B 16.37B 30.65B 2,038B 31.26B 210B 81.25B 1,005B 81.07B 79.29B 3,493B | 23.36B 20.55B 18.93B 17.71B 33.16B 2,204B 33.81B 227B 87.89B 1,087B 87.7B 85.77B 3,779B |
| Net income | 3.88B 3.41B 3.14B 2.94B 5.5B 366B 5.61B 37.72B 14.59B 180B 14.56B 14.24B 627B | 4.12B 3.62B 3.34B 3.12B 5.85B 389B 5.96B 40.08B 15.5B 192B 15.47B 15.13B 666B |
| Net Debt | 7.16B 6.3B 5.8B 5.43B 10.16B 676B 10.36B 69.66B 26.94B 333B 26.88B 26.29B 1,158B | 4.08B 3.59B 3.3B 3.09B 5.79B 385B 5.9B 39.66B 15.34B 190B 15.3B 14.97B 659B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-25 | US$44.20 | -0.58% | 19,820,589 |
| 26-06-24 | US$44.46 | -2.50% | 20,964,012 |
| 26-06-23 | US$45.60 | +2.86% | 18,696,071 |
| 26-06-22 | US$44.33 | -2.12% | 16,784,721 |
| 26-06-18 | US$45.29 | +0.76% | 30,854,998 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
